Analyst sentiment from major investment banks rates CVS Health stock as “Overweight,” with medium-term forecasts for 2025 banking on improved operating cash flow and strategic acquisitions. READ NEXT: $30 Trillion Opportunity: 15 Best Humanoid Robot Stocks to Buy According to Morgan Stanley and Jim Cramer Says NVIDIA ‘Has Become A Wasteland.’ Higher Medical Costs Likely Weighed On CVS Health’s Q1 Earnings
Return this item within 90 days of purchase.
Get an immediate answer with AI
AI-generated from the text of manufacturer documentation. To verify or get additional information, please contact The Home Depot customer service.